Longeveron LLC (NYSE: LGVN) — Healthcare · Share Price, Chart & Market Data
About: Longeveron Inc., a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions in the United States. Its lead investigational product is the LOMECEL-B, an allogeneic mesenchymal stem cell formulation sourced from the bone marrow of young and healthy adult donors which is in phase 3 clinical trial to treat hypoplastic left heart syndrome; completed phase 2a clinical trial to treat Alzheimer's disease, as well as in phase 2b clinical trial to treat aging frailty. The company was incorporated in 2014 and is headquartered in Miami, Florida.
Sector: Healthcare
Industry: Biotechnology
Latest price: $0.87 (-2.10%)
LGVNLongeveron LLC
Loading watchlist status…
Trade LGVN now
Longeveron LLC share price
LGVN price activity
Last Price
Change (24hr)
USD (%)
Volume
Volume (4w avg)
Previous Close
N/A
Last Trade
Delayed
30 Apr, 4:34 am GMT+0
LGVN price performance
-11.358%
5D
-6.975%
1M
45.953%
YTD
-45.906%
1Y
LGVN price fundamentals
N/A
Shares Issued
N/A
Dividends Per Share (DPS)
N/A
Earnings Per Share (EPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
NYSE rank
N/A
Sector Rank
N/A
Delayed
30 Apr, 4:34 am GMT+0
LGVN details
LGVN Market Signals